#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Epilepsy with myoclonic-atonic seizures Mucous membrane pemphigoid Cluster headache Retinopathy of prematurity Immune thrombocytopenia Porphyria non-acute Hepatoblastoma Osteosarcoma Anal cancer recurrent Paget's disease of the vulva White matter lesion Spinal cord injury Congenital growth hormone deficiency Pulmonary tuberculosis Hereditary angioedema with C1 esterase inhibitor deficiency More trials…

    Learn about Rare Diseases

    Retinoblastoma – Diagnostics IgA nephropathy – Basic Information CADASIL – Diagnostics Myelodysplastic syndrome with excess blasts – Treatment Paraneoplastic neurological syndrome – Life with Disease Idiopathic pulmonary fibrosis – Diagnostics Mantle cell lymphoma refractory – Trials in Disease Factor IX deficiency Hereditary angioedema with C1 esterase inhibitor deficiency – Basic Information SAPHO syndrome – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Calcium Levofolinate Bisoprolol Atropine Sulfate Magnesium Hydroxide Haloperidol Tegoprubart [68GA]GA-NOTA-AE105 Betaine Citrate Av-Ec2023 Bupivacaine Hydrochloride Capivasertib Docetaxel Landiolol Hydrochloride Ribonucleic Acid K10 Vilobelimab HUMAN PLASMA Guanfacine COBALAMIN Gadoxetic Acid, Disodium ATIGOTATUG More therapies…

    Learn about Your Condition

    Restless legs syndrome Pulmonary tuberculosis Sleep disorder Herpes simplex meningitis Pustular psoriasis Hypoparathyroidism Infertility male Follicular lymphoma stage II Von Hippel-Lindau disease Psychogenic seizure IgA nephropathy Heart transplant Oral lichen planus Anal fistula Dysmenorrhoea More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Vaccine

  • Study on the Effectiveness and Safety of Metronidazole, Neomycin Sulfate, and Nystatin for Women with Bacterial Vaginosis and Yeast Infections

    Not yet recruiting

    4 1 1 1
    Investigated Diseases:
    • Vulvovaginal candidiasis
    • Bacterial vaginosis
    Investigated Drugs:
    • Neomycin Sulfate
    • Nystatin
    • Metronidazole
    Romania

  • Study Comparing Thiamazole and Sodium Iodide (131I) for Treating Hyperthyroidism in Patients with Graves’ Disease and Active Graves’ Orbitopathy

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Graves’ disease
    Investigated Drugs:
    • Sodium Iodide (131I)
    • Thiamazole
    Italy

  • Study of Azithromycin, Doxycycline, and Sodium Ascorbate for Patients with Early-Stage Breast Cancer

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Breast cancer female
    • Breast cancer
    Investigated Drugs:
    • Azithromycin Dihydrate
    • Sodium Ascorbate
    • Doxycycline Hyclate
    Italy

  • Study on the Role of Vitamin D (Colecalciferol) in Preventing Graft-Versus-Host Disease in Patients Undergoing Stem Cell Transplantation

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Blood disorder
    Investigated Drugs:
    • Colecalciferol
    Italy

  • Study on Multiple Myeloma Treatment with Isatuximab, Lenalidomide, and Carfilzomib for Patients Under 66 Eligible for Stem Cell Transplant

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Plasma cell myeloma
    Investigated Drugs:
    • Iberdomide
    • Carfilzomib
    • Dexamethasone
    Belgium France

  • Study on Rituximab, Tocilizumab, and Tofacitinib for Patients with Granulomatosis with Polyangiitis Not Responding to Standard Therapy

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Granulomatosis with polyangiitis
    Investigated Drugs:
    • Tofacitinib
    • Azathioprine
    • Methotrexate
    France
Previous Page
1 … 866 867 868 869 870 … 1,675
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!